A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1
Clinical trial NCT04152200 · COMPLETED
Trial details
- NCT number
- NCT04152200
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2021-05-18
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.